CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Revolution Medicines Inc   (NASDAQ: RVMD)
Other Ticker:  
 
 

RVMD's Revenue Growth by Quarter and Year

Revolution Medicines Inc 's Revenue results by quarter and year




RVMD Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December 0.00 0.74 15.33 9.46
III Quarter September 0.00 0.00 3.36 1.10
II Quarter June 0.00 3.82 9.12 8.70
I Quarter March 0.00 7.01 7.58 10.13
FY   0.00 11.57 35.39 29.39



RVMD Revenue fourth quarter 2024 Y/Y Growth Comment
Revolution Medicines Inc in the fourth quarter 2024 recorded of $ 0.00 millions.

According to the results reported in the fourth quarter 2024, Revolution Medicines Inc achieved the best Revenue growth in Biotechnology & Pharmaceuticals industry. While Revolution Medicines Inc ' s Revenue no change of % ranks overall at the positon no. in the fourth quarter 2024.


RVMD Revenue ( Y/Y Growth %) 2024
 2023 2022 2021
IV Quarter December - -95.17 % 62.05 % 8.11 %
III Quarter September - - 205.45 % -91.31 %
II Quarter June - -58.11 % 4.83 % -13.26 %
I Quarter March - -7.52 % -25.17 % -12.29 %
FY   - -67.31 % 20.42 % -31.64 %

Financial Statements
Revolution Medicines Inc 's fourth quarter 2024 Revenue $ 0.00 millions RVMD's Income Statement
Revolution Medicines Inc 's fourth quarter 2023 Revenue $ 0.74 millions Quarterly RVMD's Income Statement


RVMD Revenue (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
IV Quarter December - - 356.25 % 760 %
III Quarter September - - -63.16 % -87.36 %
II Quarter June - -45.51 % 20.32 % -14.12 %
I Quarter March - -54.27 % -19.87 % 15.77 %
FY (Year on Year)   - -67.31 % 20.42 % -31.64 %


Back to RVMD Growth rate Comparisons >> Back to RVMD Growth rate Comparisons >>


Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Revolution Medicines Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RVMD's IV. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


RVMD's IV. Quarter Q/Q Revenue Comment


Revolution Medicines Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the Dec 31 2024 period, Revolution Medicines Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Revolution Medicines Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Dec 31 2024 period, Revolution Medicines Inc 's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Revolution Medicines Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
RVMD's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for RVMD's Competitors
Revenue Growth for Revolution Medicines Inc 's Suppliers
Revenue Growth for RVMD's Customers

You may also want to know
RVMD's Annual Growth Rates RVMD's Profitability Ratios RVMD's Asset Turnover Ratio RVMD's Dividend Growth
RVMD's Roe RVMD's Valuation Ratios RVMD's Financial Strength Ratios RVMD's Dividend Payout Ratio
RVMD's Roa RVMD's Inventory Turnover Ratio RVMD's Growth Rates RVMD's Dividend Comparisons



Companies with similar Revenue no change for the quarter ending Dec 31 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2024
Adapthealth Corp -0.19%$ -0.185 millions
Bioaffinity Technologies Inc -0.26%$ -0.260 millions
Organon and Co -0.38%$ -0.375 millions
Royalty Pharma Plc-0.41%$ -0.407 millions
Cytek Biosciences Inc -0.59%$ -0.586 millions
Kronos Bio Inc -0.70%$ -0.700 millions
Enhabit Inc -0.92%$ -0.921 millions
Charles River Laboratories International inc -1.08%$ -1.078 millions
Elanco Animal Health Inc-1.45%$ -1.449 millions
Illumina Inc -1.60%$ -1.604 millions
Perrigo Company Plc-1.68%$ -1.683 millions
Fonar Corporation-1.72%$ -1.717 millions
Steris Plc-1.80%$ -1.797 millions
Bio rad Laboratories Inc -1.91%$ -1.910 millions
Surmodics Inc -2.06%$ -2.062 millions
Petvivo Holdings Inc -2.11%$ -2.111 millions
Iridex Corp-2.15%$ -2.153 millions
Assertio Holdings inc -2.43%$ -2.431 millions
Apyx Medical Corp-2.58%$ -2.578 millions
Bioxcel Therapeutics Inc -2.66%$ -2.660 millions
Zynex inc -2.66%$ -2.665 millions
National Research Corporation-2.88%$ -2.879 millions
Teladoc Health Inc -3.03%$ -3.033 millions
Elutia inc -3.15%$ -3.155 millions
Orchestra Biomed Holdings Inc -3.44%$ -3.435 millions
Regenxbio Inc -4.50%$ -4.497 millions
Exagen Inc -4.64%$ -4.642 millions
Sanofi-4.65%$ -4.647 millions
Alpha Pro Tech Ltd -4.68%$ -4.682 millions
Quidelortho Corp-4.69%$ -4.686 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com